Insitro is a Biotech company based in Hillsborough, CA. It has raised $150M in total funding. Latest round: Series C.
Insitro funding overview
Insitro is a Biotech company based in Hillsborough, CA. Insitro has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for Insitro runs through 2021; nothing later has been disclosed. Investors on record include Canada Pension Plan Investment Board, Andreessen Horowitz, T. Rowe Price Associates, Inc., Casdin Capital, BlackRock, ARCH Venture Partners and 8 others. 14 distinct backers are named across the disclosed rounds.
Insitro has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Insitro?
Canada Pension Plan Investment Board, Andreessen Horowitz, T. Rowe Price Associates, Inc., Casdin Capital, BlackRock, ARCH Venture Partners are named among the investors backing Insitro.
What was the latest Insitro funding round?
The most recent disclosed round is a Series C, announced in March 2021.
Where is Insitro based?
Insitro is based in Hillsborough, CA.
What sector does Insitro operate in?
Insitro is tracked under Biotech from Hillsborough, CA, with $150M in disclosed funding.
When did Insitro last raise?
The last disclosed Insitro round closed in March 2021 at Series C.
Every Insitro figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Hillsborough at a similar stage.
